Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$223M |
| 2 |
CVS Health
CVS
|
+$18.9M |
| 3 |
American International
AIG
|
+$16.3M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$13.4M |
| 5 |
TJX Companies
TJX
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$12.6M |
| 2 |
Crown Castle
CCI
|
+$7.91M |
| 3 |
Eli Lilly
LLY
|
+$7.58M |
| 4 |
RTX Corp
RTX
|
+$7.28M |
| 5 |
Deere & Co
DE
|
+$7.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.16% |
| 2 | Consumer Discretionary | 11.77% |
| 3 | Financials | 11.5% |
| 4 | Healthcare | 9.84% |
| 5 | Technology | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Jazz Pharmaceuticals
JAZZ
$14B
| $2.4M | 0.15% |
+17,000
| New | +$2.51M |
2016 Q2
0 quarters
|
|
152
Acadia Pharmaceuticals
ACAD
$3.55B
| $2.39M | 0.15% |
+73,600
| New | +$2.46M |
2016 Q2
0 quarters
|
|
153
Eastman Chemical
EMN
$7.61B
| $2.33M | 0.15% |
34,262
+18,323
| +115% | +$1.35M |
2015 Q3
3 quarters
|
|
154
DELISTED
Westar Energy Inc
WR
| $2.32M | 0.15% |
41,449
+31,977
| +338% | +$1.69M |
2015 Q4
2 quarters
|
|
155
Assurant
AIZ
$14.4B
| $2.31M | 0.14% |
+26,798
| New | +$2.25M |
2016 Q2
0 quarters
|
|
|
CTXS
156
DELISTED
Citrix Systems Inc
CTXS
| $2.31M | 0.14% |
36,212
+16,244
| +81% | +$1.07M |
2016 Q1
1 quarter
|
|
157
TransDigm Group
TDG
$63.4B
| $2.31M | 0.14% |
8,746
+4,346
| +99% | +$1.06M |
2015 Q4
2 quarters
|
|
158
Northern Trust
NTRS
$30.6B
| $2.29M | 0.14% |
+34,583
| New | +$2.41M |
2016 Q2
0 quarters
|
|
159
DELISTED
Praxair Inc
PX
| $2.29M | 0.14% |
20,377
+16,129
| +380% | +$1.83M |
2015 Q4
2 quarters
|
|
160
DaVita
DVA
$11.8B
| $2.28M | 0.14% |
+29,497
| New | +$2.23M |
2016 Q2
0 quarters
|
|
161
PayPal
PYPL
$47.4B
| $2.27M | 0.14% |
62,174
-9,329
| -13% | -$357K |
2015 Q3
3 quarters
|
|
162
DELISTED
Kellanova
K
| $2.26M | 0.14% |
29,508
-5,343
| -15% | -$383K |
2016 Q1
1 quarter
|
|
|
EQY
163
DELISTED
Equity One
EQY
| $2.23M | 0.14% |
69,348
+31,881
| +85% | +$934K |
2016 Q1
1 quarter
|
|
164
West Pharmaceutical
WST
$28.7B
| $2.22M | 0.14% |
+29,296
| New | +$2.13M |
2016 Q2
0 quarters
|
|
|
WCG
165
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.22M | 0.14% |
20,710
+12,526
| +153% | +$1.23M |
2016 Q1
1 quarter
|
|
166
State Street SPDR S&P Regional Banking ETF
KRE
$4.3B
| $2.22M | 0.14% |
+57,834
| New | +$2.29M |
2016 Q2
0 quarters
|
|
|
CY
167
DELISTED
Cypress Semiconductor
CY
| $2.22M | 0.14% |
210,232
+189,416
| +910% | +$1.8M |
2016 Q1
1 quarter
|
|
168
Kinder Morgan
KMI
$75.5B
| $2.22M | 0.14% |
118,381
-168,459
| -59% | -$3M |
2015 Q2
4 quarters
|
|
169
Revvity
RVTY
$17.5B
| $2.21M | 0.14% |
42,152
+10,654
| +34% | +$560K |
2016 Q1
1 quarter
|
|
170
Analog Devices
ADI
$202B
| $2.2M | 0.14% |
+38,865
| New | +$2.23M |
2016 Q2
0 quarters
|
|
171
Pool Corp
POOL
$7.36B
| $2.2M | 0.14% |
23,361
+13,566
| +138% | +$1.22M |
2016 Q1
1 quarter
|
|
|
PNY
172
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $2.19M | 0.14% |
+36,491
| New | +$2.19M |
2016 Q2
0 quarters
|
|
173
Cisco
CSCO
$412B
| $2.19M | 0.14% |
76,379
+6,950
| +10% | +$195K |
2015 Q4
2 quarters
|
|
174
Williams-Sonoma
WSM
$29.8B
| $2.19M | 0.14% |
83,986
+55,850
| +199% | +$1.53M |
2015 Q4
2 quarters
|
|
|
FEIC
175
DELISTED
FEI COMPANY
FEIC
| $2.18M | 0.14% |
20,419
+16,342
| +401% | +$1.56M |
2016 Q1
1 quarter
|
|
Similar funds
Squarepoint's Q2 2016 Portfolio in Review
As of Q2 2016, Squarepoint held 1,549 positions worth $1.6B, up 24% from $1.29B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Squarepoint deployed $307M of net new capital in Q2 2016, opening 435 new positions and adding to 314 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Crown Castle, an estimated $7.91M trimmed.
- Squarepoint's largest Q2 2016 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
- Squarepoint added most to CVS Health in Q2 2016, an estimated $18.9M increase.
- Squarepoint's biggest Q2 2016 reduction was Crown Castle, cutting an estimated $7.91M.
- Squarepoint fully exited Chubb in Q2 2016, selling an estimated $12.6M.
- Squarepoint's ten largest holdings make up 23% of its $1.6B portfolio in Q2 2016.
- Squarepoint opened 435 new positions and closed 482 in Q2 2016.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $1.6B.
Based on Squarepoint's 13F filing for Q2 2016, filed 15 Aug 2016.